Status:
COMPLETED
Gastrointestinal Motility in Patients With Neuroendocrine Tumors
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Novartis
The Danish Medical Research Council
Conditions:
Neuroendocrine Tumor
Eligibility:
All Genders
30-80 years
Brief Summary
We will study the total gastrointestinal transit time (GITT), gastric emptying and small intestine motility in NET patients before and after treated with somatostatin analogues and compare these to he...
Eligibility Criteria
Inclusion
- NET confirmed by histology
- Diarrhea, (at least 3 loose or watery bowel movements per day) as part of carcinoid syndrome.
- Newly referred patients without previous somatostatin analogue treatment or
- NET patients who are pausing somatostatin analogue treatment due to other treatment or examination.
Exclusion
- Subjects unable to understand the information
- Severe diabetes with late complications or known metabolic disorder
- Inflammatory bowel disease
- Known clinically significant stenosis of the bowel
- Bile acid malabsorption due to intestinal surgery
- Small bowl bacterial overgrowth
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00789841
Start Date
September 1 2008
End Date
May 1 2010
Last Update
October 26 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Analfysiologisk afsnit, Aarhus University Hospital, Tage Hansensgade, entrance 11A
Aarhus, Aarhus, Denmark, 8000